The Puzzle of Pancreatic Cancer
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030.
Progress Against Cancer
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030.
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
The Cytosponge provides a cheaper alternative to an endoscopy.
The American Society for Radiation Oncology created guidelines to address controversies over when radiation should be used.
Typically, patients are treated with heparin, an injectable blood thinner, after a blood clot develops, but updated guidelines support use of oral blood thinners.
Some patients may find their doctor recommends cryoablation, a less invasive procedure that uses extreme cold to kill cancer cells, as an alternative to surgery or radiation.
Cancer Today editor-in-chief William G. Nelson, MD, PhD, discusses emerging insights into epigenetic abnormalities in cancer cells.
Screening for lung cancer using low-dose computed tomography (CT) was introduced in the United States in 2013. Recent data from the Centers for Disease Control and Prevention (CDC) showed that only one in eight people for whom lung cancer screening was recommended reported having been screened in the past year, even as long-term results from a large randomized clinical trial provided confirmation that screening reduces lung cancer death rates.
An update on how the spread of coronavirus is impacting cancer care, and more news of the week from Cancer Today.
Cancer patients in the U.S. are feeling impacts from the new coronavirus. Doctors are rescheduling routine follow-up visits and encouraging telehealth visits when possible.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More